Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001165527-15-000396
Filing Date
2015-08-11
Accepted
2015-08-11 17:01:43
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 g7955.htm 10-Q 698127
2 ex31-1.htm EX-31.1 15302
3 ex31-2.htm EX-31.2 15314
4 ex32.htm EX-32 6621
  Complete submission text file 0001165527-15-000396.txt   3207571

Data Files

Seq Description Document Type Size
5 clcs-20150630.xml EX-101.INS 623902
6 clcs-20150630.xsd EX-101.SCH 31270
7 clcs-20150630_cal.xml EX-101.CAL 24169
8 clcs-20150630_def.xml EX-101.DEF 87248
9 clcs-20150630_lab.xml EX-101.LAB 251409
10 clcs-20150630_pre.xml EX-101.PRE 182641
Mailing Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128 18889709463
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 151044629
SIC: 2834 Pharmaceutical Preparations